Recombinant Bromodomain Containing Protein 2 (BRD2)
Cat#:TP01366应用:Positive Control; Immunogen; SDS-PAGE; WB
Product Name: | BRD2 Rabbit pAb |
Cat No.: | DPA04792 |
Clonality: | Polyclonal |
Species Reactivity: | Human |
Tested Applications: | WB,IHC,ICC/IF,FC |
Recommended Dilution: | WB: 1:2000 IHC: 1:50 ICC/IF: 1:50 FC: 1:50 |
Size: | 30ul 50ul 100uL |
Format: | Liquid |
Source: | Rabbit |
Purification Method: | Affinity Purification |
Isotype: | IgG |
Conjugate: | Un-conjugated |
Storage: | Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide a |
Immunogen: | A synthetic peptide of human BRD2 |
Calculated Molecular Weight: | 88 kDa |
Observed Molecular Weight: | 110 kDa |
GenBank Accession Number: | P25440 |
Gene ID (NCBI): | 6046 |
Synonyms: | FSH; NAT; RNF3; FSRG1; RING3; D6S113E; O27.1.1; BRD2-IT1 |
Background: | This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene. [provided by RefSeq, Dec 2010] |
Category: | Primary Ab |